Originally Posted by HowlerKarma
ADHD is a condition that is central to Pearson’s vision



One muses... wonder what the nature of Pearson's pharma holdings looks like these days...

wink
Not sure about their pharma holdings, but I do know that, since purchasing CogMed a couple of years ago, they have been aggressively marketing it to schools and clinics as a treatment for working memory and attention (aka, ADHD). Despite hedgy efficacy results.

...pronounced like the long vowel and first letter of the alphabet...